HemaSphere (Jun 2022)

P627: COMBINED DRUG AND CRISPR/CAS9 SCREENING REVEALS SPECIFIC TARGETS FOR SF3B1- AND NOTCH1-MUTATED CLL CELLS

  • L. Dostálová,
  • A. Ladungová,
  • D. Škrnová,
  • N. Varma Gottumukkala,
  • Y. Lodhi,
  • M. Smida

DOI
https://doi.org/10.1097/01.HS9.0000845396.09812.76
Journal volume & issue
Vol. 6
pp. 526 – 527

Abstract

Read online

No abstracts available.